Sentence: YM155 in combination with rituximab was tolerable with encouraging antitumor activity and durable responses in relapsed aggressive B-cell NHL patients .
Drug combination annotation:
[{'class': 'POS', 'spans': ['YM155', 'rituximab'], 'is_context_needed': False}]